Furlanut M, Montanari G, Perosa A, Velussi C, Forgione A, Palatini P
Int J Clin Pharmacol Res. 1985;5(3):165-70.
Flunoxaprofen is a new nonsteroidal antiinflammatory agent that, like benoxaprofen, inhibits leukotriene rather than prostaglandin synthesis. The absorption and disposition kinetics of flunoxaprofen and benoxaprofen have been compared in six healthy volunteers after oral administration of 100 mg of each drug. The two drugs showed similar absorption characteristics, whereas the distribution and elimination processes were much faster for flunoxaprofen. The renal route of elimination appeared to contribute significantly less to the disposition of flunoxaprofen. These kinetic characteristics render less likely the risk of excessive drug accumulation with flunoxaprofen, especially in the presence of reduced renal function.
氟诺昔康是一种新型非甾体抗炎药,与贝诺昔康一样,它抑制白三烯的合成而非前列腺素的合成。在6名健康志愿者口服100毫克每种药物后,对氟诺昔康和贝诺昔康的吸收及处置动力学进行了比较。两种药物显示出相似的吸收特性,而氟诺昔康的分布和消除过程要快得多。肾脏消除途径对氟诺昔康处置的贡献似乎要小得多。这些动力学特征降低了氟诺昔康药物过度蓄积的风险,尤其是在肾功能减退的情况下。